Jonathan Abelson to Neoadjuvant Therapy
This is a "connection" page, showing publications Jonathan Abelson has written about Neoadjuvant Therapy.
Connection Strength
1.195
-
Connolly JG, McCullum JC, Munroe C, Gaetani RS, Bliggenstorfer JT, Saraidaridis JT, Kuhnen AH, Marcello PW, Kleiman DA, Abelson JS. Circumferential Rectal Cancer Is a Risk Factor for Stricture Formation and Restaging Uncertainties After Neoadjuvant Therapy. Dis Colon Rectum. 2026 02 01; 69(2):181-190.
Score: 0.878
-
Gaetani RS, Sharma S, Rizvi TZ, Abelson JS. Quality of Life and Functional Outcomes After Watch-and-Wait for Locally Advanced Rectal Cancer: A Meta-analysis. J Surg Res. 2025 11; 315:362-375.
Score: 0.218
-
Boysen M, Lai SH, Byers S, Widmar M, Loria A, Russell T, Abelson JS, Fleming FJ, Monson JR, Vogel JD. Rectal Cancer Watch-and-Wait Management of Patients With Tumors Within Versus Beyond the Reach of Digital Rectal Examination. Ann Surg Oncol. 2026 Apr; 33(4):2856-2864.
Score: 0.055
-
Spencer SB, Abelson J, Kleiman DA. Total Neoadjuvant Therapy Decreases Time to Ileostomy Reversal for Locally Advanced Rectal Cancer. Dis Colon Rectum. 2022 09 01; 65(9):e914.
Score: 0.043